← Back to catalogue

OptaBlate

FDA UDI

Class II (US FDA UDI)

by Stryker Corp.

Identity

Trade Name
OptaBlate FDA UDI
Generic Name
Percutaneous radio-frequency ablation probe, tumour-ablation, bipolar FDA UDI
Device Name
Straight 15mm Probe Dual Kit FDA UDI
Model / Reference
9700015200 FDA UDI
Description
Straight 15mm Probe Dual Kit FDA UDI

Identifiers

Catalog Number
9700-015-200 FDA UDI
Primary DI / UDI-DI
07613327524512 FDA UDI
FDA Product Code
GEI FDA UDI
GMDN Term
Percutaneous radio-frequency ablation probe, tumour-ablation, bipolar FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
878.4400 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Dimensions & Sizes

Size
Length — 15.0 Millimeter FDA UDI

Category: Percutaneous radio-frequency ablation probe, tumour-ablation, bipolar

OptaBlate by Stryker Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Percutaneous radio-frequency ablation probe, tumour-ablation, bipolar.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Stryker Corp.

Sources (1)

  • FDA UDI d31b533b-2a9b-4a7d-bf3f-abed50e0097a 37 fields · synced May 31, 2026